We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

ARRAY MARKET (LIFE SCIENCE AND BIOTECHNOLOGY INSTRUMENTS) ANALYSIS

Array Market (Life Science and Biotechnology Instruments), By Type, By End User, And By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) -

  • Published In : Aug 2023
  • Code : CMI4221
  • Pages :247
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market Challenges And Opportunities

Restraints & Challenges:

  • High cost of Microarray Sequencing
  • Lack of technically trained resources
    • Global Array Market (Life Science and Biotechnology Instruments) – Impact of Coronavirus (COVID-19) Pandemic

      Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020.

      The COVID-19 pandemic had a positive impact on the global array market (Life Science and Biotechnology Instruments), owing to increased research and development activities using array in the treatment of patients suffering from COVID-19. For instance, in August 2020, according to the report published by Aurora Biomed Inc., a provider of lab automation solutions for life science, environmental science, drug discovery and safety and chemical analysis research, microarray, including cell microarray, protein microarrays, and DNA and RNA microarray, are all considered powerful tools in the ongoing research related to COVID-19. These microarrays can analyze hundreds or even thousands of samples in a single run, making them much faster than traditional virus detection methods. These techniques allow researchers to rapidly screen for the presence of viral proteins in samples, providing valuable information about the virus and its behavior.

      Furthermore, in January 2022, according to the published article titled "Systematic Investigation of SARS-CoV-2 Receptor Protein Distribution along Viral Entry Routes in Humans", tissue microarrays incorporating a total of 879 tissue cores from conjunctival (n = 84), sinonasal (n = 95), and lung (bronchiolar/alveolar; n = 96) specimens were investigated for protein expression by immunohistochemistry. The study confirms and extends previous findings and contributes to a better understanding of potential SARS-CoV-2 infection sites along the human respiratory tract. Such studies indicate significant demand for tissue microarray products amid the pandemic.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.